Levels of adiponectin are lowered in conditions such as diabetes mellitus [30], hypertension [31], coronary diseases [32] and in obese patients [33], since it is negatively related to the amount of visceral adipose tissue in agreement with the above [34]. This evidence concerns the gene ADIPOQ and hypertensive disorder.